ViroGates A/S (VIRO.CO)
DKK 13.2
(0.76%)
DKK 13.2
(0.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.17 Million | -14.27 Million | -21.43 Million | -15.6 Million | -18.07 Million | -16.38 Million |
| Net Income | -12.09 Million | -9.64 Million | -17.66 Million | -18.73 Million | -18.79 Million | -16.98 Million |
| Depreciation & Amortization | 40 Thousand | 175 Thousand | 217 Thousand | 229 Thousand | 116 Thousand | 125 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -359 Thousand | -4.87 Million | -3.93 Million | 2.93 Million | -110 Thousand | 701 Thousand |
| Other non-cash items | 236 Thousand | 72 Thousand | -55 Thousand | -34 Thousand | 718 Thousand | -220 Thousand |
| Investing Cash Flow | 12 Thousand | -13 Thousand | -4000.00 | -114 Thousand | -603 Thousand | -2000.00 |
| Investments in PPE | - | - | - | -114 Thousand | -546 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -13 Thousand | -4000.00 | - | -57 Thousand | -2000.00 |
| Sales/Maturities of investments | 12 Thousand | - | - | - | - | - |
| Other Investing Activities | 12 Thousand | -13 Thousand | -4000.00 | - | -57 Thousand | -2000.00 |
| Financing Cash Flow | 18.31 Million | 9.3 Million | 2.77 Million | 7.83 Million | - | 75 Million |
| Debt repayment | -5.3 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.01 Million | 9.3 Million | 2.77 Million | 7.83 Million | - | 75 Million |
| Other Financing Activities | 10.6 Million | 9.3 Million | 2.77 Million | 7.83 Million | - | 75 Million |
| Accounts receivables | 213 Thousand | -450 Thousand | -18 Thousand | -534 Thousand | -944 Thousand | 268 Thousand |
| Accounts payables | 797 Thousand | -2.35 Million | -3.12 Million | 3.99 Million | 530 Thousand | - |
| Inventory | -1.36 Million | -2.07 Million | -788 Thousand | -517 Thousand | 304 Thousand | 1000.00 |
| Other working capital | 797 Thousand | -1000.00 | -1000.00 | 3.99 Million | 530 Thousand | 700 Thousand |
| Cash at beginning of period | 9.87 Million | 14.85 Million | 33.52 Million | 41.4 Million | 60.08 Million | 1.46 Million |
| Cash at end of period | 16.02 Million | 9.87 Million | 14.85 Million | 33.52 Million | 41.4 Million | 60.08 Million |
| Capital Expenditure | - | - | - | -114 Thousand | -546 Thousand | - |
| Effect of forex changes on cash | 1000.00 | - | -1000.00 | - | - | - |
| Net cash flow / Change in cash | 6.14 Million | -4.98 Million | -18.66 Million | -7.88 Million | -18.67 Million | 58.61 Million |
| Free Cash Flow | -12.17 Million | -14.27 Million | -21.43 Million | -15.71 Million | -18.61 Million | -16.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.09 Million | -3.59 Million | -3.31 Million | -12.09 Million | -2.12 Million | -3.71 Million |
| Depreciation & Amortization | - | - | 5000.00 | 40 Thousand | 9000.00 | 9000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 882 Thousand | 68 Thousand | -1.28 Million | -359 Thousand | 274 Thousand | 811 Thousand |
| Other non-cash items | -1.16 Million | -338 Thousand | 1.17 Million | 236 Thousand | -286 Thousand | -320 Thousand |
| Investing Cash Flow | -1000.00 | - | 12 Thousand | 12 Thousand | - | -19 Thousand |
| Investments in PPE | -1000.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 12 Thousand | 12 Thousand | - | -19 Thousand |
| Other Investing Activities | - | - | 12 Thousand | 12 Thousand | - | - |
| Financing Cash Flow | - | - | 13.01 Million | 18.31 Million | 5.3 Million | 5.3 Million |
| Debt repayment | - | - | - | -5.3 Million | -5.3 Million | -5.3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 13.01 Million | 13.01 Million | - | - |
| Other Financing Activities | - | - | 13.01 Million | 10.6 Million | 10.6 Million | 5.3 Million |
| Accounts receivables | 279 Thousand | 118 Thousand | -507 Thousand | 213 Thousand | -582 Thousand | 1.48 Million |
| Accounts payables | 159 Thousand | -512 Thousand | 302 Thousand | 797 Thousand | 775 Thousand | -115 Thousand |
| Inventory | 444 Thousand | 462 Thousand | -1.08 Million | -1.36 Million | 82 Thousand | -541 Thousand |
| Other working capital | 159 Thousand | -512 Thousand | 302 Thousand | 797 Thousand | -1000.00 | -18 Thousand |
| Cash at beginning of period | 12.22 Million | 16.02 Million | 6.42 Million | 9.87 Million | 8.55 Million | 6.46 Million |
| Cash at end of period | 8.73 Million | 12.22 Million | 16.02 Million | 16.02 Million | 6.42 Million | 8.55 Million |
| Capital Expenditure | -1000.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 1000.00 | 1000.00 | - | 19 Thousand |
| Net cash flow / Change in cash | -3.49 Million | -3.79 Million | 9.6 Million | 6.14 Million | -2.13 Million | 2.08 Million |
| Free Cash Flow | -3.49 Million | -3.79 Million | -3.42 Million | -12.17 Million | -2.13 Million | -3.21 Million |
EMD
7513
0442
7219
ORI
ARIS